0.00Open0.00Pre Close0 Volume0 Open Interest90.00Strike Price0.00Turnover741.80%IV-16.02%PremiumDec 13, 2024Expiry Date12.43Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8565Delta0.0221Gamma6.44Leverage Ratio-9.9175Theta-0.0002Rho-5.51Eff Leverage0.0031Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet